Immune suppression in gliomas

INTRODUCTION: The overall survival in patients with gliomas has not significantly increased in the modern era, despite advances such as immunotherapy. This is in part due to their notorious ability to suppress local and systemic immune responses, severely restricting treatment efficacy. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Grabowski, Matthew M., Sankey, Eric W., Ryan, Katherine J., Chongsathidkiet, Pakawat, Lorrey, Selena J., Wilkinson, Daniel S., Fecci, Peter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Topic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843555/
https://www.ncbi.nlm.nih.gov/pubmed/32542437
http://dx.doi.org/10.1007/s11060-020-03483-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843555/
https://www.ncbi.nlm.nih.gov/pubmed/32542437
http://dx.doi.org/10.1007/s11060-020-03483-y

Ejemplares similares